Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|3|3|194-200

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.3, Iss.3, 2008-11, pp. : 194-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists

By  

Current Vascular Pharmacology, Vol. 13, Iss. 5, 2015-01 ,pp. : 566-577

Bentham Science Publishers

Access to resources Recommend Favorite

Usefulness of thrombelastography platelet mapping assay to measure the antiplatelet effect of P2Y12 receptor inhibitors and high on-treatment platelet reactivity

By Jeong Young-Hoon   Bliden Kevin P.   Antonino Mark J.   Tantry Udaya S.   Gurbel Paul A.  

Platelets, Vol. 24, Iss. 2, 2013-03 ,pp. : 166-169

Informa Healthcare

Access to resources Recommend Favorite

P2Y12 receptor in platelet activation

By Kim Soochong   Kunapuli Satya P.  

Platelets, Vol. 22, Iss. 1, 2011-02 ,pp. : 54-58

Informa Healthcare

Access to resources Recommend Favorite

Effects of P2Y1 and P2Y12 receptor antagonists on platelet aggregation induced by different agonists in human whole blood

By Storey Robert F.   Newby Linda J.   Heptinstall Stan  

Platelets, Vol. 12, Iss. 7, 2001-11 ,pp. : 443-447

Informa Healthcare

Access to resources Recommend Favorite

The relative importance of the ADP receptors, P2Y 12 and P2Y 1 , in thrombin-induced platelet activation

By Nylander S.   Mattsson C.   Ramstrom S.   Lindahl T.L.  

Thrombosis Research, Vol. 111, Iss. 1, 2003-01 ,pp. : 65-73

Elsevier

Access to resources Recommend Favorite